166 related articles for article (PubMed ID: 20074569)
1. NMR characterization of the interactions between lyso-GM1 aqueous micelles and amyloid beta.
Yagi-Utsumi M; Kameda T; Yamaguchi Y; Kato K
FEBS Lett; 2010 Feb; 584(4):831-6. PubMed ID: 20074569
[TBL] [Abstract][Full Text] [Related]
2. The interaction of amyloid Abeta(1-40) with lipid bilayers and ganglioside as studied by 31P solid-state NMR.
Nakazawa Y; Suzuki Y; Williamson MP; Saitô H; Asakura T
Chem Phys Lipids; 2009 Mar; 158(1):54-60. PubMed ID: 19138679
[TBL] [Abstract][Full Text] [Related]
3. Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching?
Watson AA; Fairlie DP; Craik DJ
Biochemistry; 1998 Sep; 37(37):12700-6. PubMed ID: 9737846
[TBL] [Abstract][Full Text] [Related]
4. Interactions of amyloid beta-peptide (1-40) with ganglioside-containing membranes.
Matsuzaki K; Horikiri C
Biochemistry; 1999 Mar; 38(13):4137-42. PubMed ID: 10194329
[TBL] [Abstract][Full Text] [Related]
5. Characterization of copper binding to the peptide amyloid-beta(1-16) associated with Alzheimer's disease.
Ma QF; Hu J; Wu WH; Liu HD; Du JT; Fu Y; Wu YW; Lei P; Zhao YF; Li YM
Biopolymers; 2006 Sep; 83(1):20-31. PubMed ID: 16615111
[TBL] [Abstract][Full Text] [Related]
6. Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component.
Okada T; Wakabayashi M; Ikeda K; Matsuzaki K
J Mol Biol; 2007 Aug; 371(2):481-9. PubMed ID: 17582434
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?
Coles M; Bicknell W; Watson AA; Fairlie DP; Craik DJ
Biochemistry; 1998 Aug; 37(31):11064-77. PubMed ID: 9693002
[TBL] [Abstract][Full Text] [Related]
8. Nicotine inhibits amyloid formation by the beta-peptide.
Salomon AR; Marcinowski KJ; Friedland RP; Zagorski MG
Biochemistry; 1996 Oct; 35(42):13568-78. PubMed ID: 8885836
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease: NMR studies of asialo (GM1) and trisialo (GT1b) ganglioside interactions with Abeta(1-40) peptide in a membrane mimic environment.
Mandal PK; Pettegrew JW
Neurochem Res; 2004 Feb; 29(2):447-53. PubMed ID: 15002743
[TBL] [Abstract][Full Text] [Related]
10. NMR studies of the Zn2+ interactions with rat and human beta-amyloid (1-28) peptides in water-micelle environment.
Gaggelli E; Janicka-Klos A; Jankowska E; Kozlowski H; Migliorini C; Molteni E; Valensin D; Valensin G; Wieczerzak E
J Phys Chem B; 2008 Jan; 112(1):100-9. PubMed ID: 18072760
[TBL] [Abstract][Full Text] [Related]
11. Simulation study on the disordered state of an Alzheimer's beta amyloid peptide Abeta(12 36) in water consisting of random-structural, beta-structural, and helical clusters.
Ikebe J; Kamiya N; Ito J; Shindo H; Higo J
Protein Sci; 2007 Aug; 16(8):1596-608. PubMed ID: 17656579
[TBL] [Abstract][Full Text] [Related]
12. Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy.
Milojevic J; Esposito V; Das R; Melacini G
J Am Chem Soc; 2007 Apr; 129(14):4282-90. PubMed ID: 17367135
[TBL] [Abstract][Full Text] [Related]
13. Two-site binding of beta-cyclodextrin to the Alzheimer Abeta(1-40) peptide measured with combined PFG-NMR diffusion and induced chemical shifts.
Danielsson J; Jarvet J; Damberg P; Gräslund A
Biochemistry; 2004 May; 43(20):6261-9. PubMed ID: 15147210
[TBL] [Abstract][Full Text] [Related]
14. Environment- and mutation-dependent aggregation behavior of Alzheimer amyloid beta-protein.
Yamamoto N; Hasegawa K; Matsuzaki K; Naiki H; Yanagisawa K
J Neurochem; 2004 Jul; 90(1):62-9. PubMed ID: 15198667
[TBL] [Abstract][Full Text] [Related]
15. Energy landscapes of the monomer and dimer of the Alzheimer's peptide Abeta(1-28).
Dong X; Chen W; Mousseau N; Derreumaux P
J Chem Phys; 2008 Mar; 128(12):125108. PubMed ID: 18376983
[TBL] [Abstract][Full Text] [Related]
16. Formation of toxic Abeta(1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: polymorphisms in Abeta(1-40) fibrils.
Okada T; Ikeda K; Wakabayashi M; Ogawa M; Matsuzaki K
J Mol Biol; 2008 Oct; 382(4):1066-74. PubMed ID: 18692507
[TBL] [Abstract][Full Text] [Related]
17. Chloroquine-induced endocytic pathway abnormalities: Cellular model of GM1 ganglioside-induced Abeta fibrillogenesis in Alzheimer's disease.
Yuyama K; Yamamoto N; Yanagisawa K
FEBS Lett; 2006 Dec; 580(30):6972-6. PubMed ID: 17161396
[TBL] [Abstract][Full Text] [Related]
18. Characterization of chemical exchange between soluble and aggregated states of beta-amyloid by solution-state NMR upon variation of salt conditions.
Narayanan S; Reif B
Biochemistry; 2005 Feb; 44(5):1444-52. PubMed ID: 15683229
[TBL] [Abstract][Full Text] [Related]
19. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
[TBL] [Abstract][Full Text] [Related]
20. Exploring interaction of beta-amyloid segment (25-35) with membrane models through paramagnetic probes.
Esposito C; Tedeschi A; Scrima M; D'errico G; Ottaviani MF; Rovero P; D'ursi AM
J Pept Sci; 2006 Dec; 12(12):766-74. PubMed ID: 17131288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
